Company / Gross Profit per Share
Tandem Diabetes Care Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$8.24
FY2025
5-year range
$3.12 / $8.24
FY2021-FY2025
Trend
+10.3%
vs FY2024
Sector context
#56 of 99
Health Care
What the data says
At $8.24, Tandem Diabetes Care's gross profit per share ranks #56 of 99 in the Health Care sector. Gross Profit per Share has increased for 6 consecutive years, from $0.77 in FY2019 to $8.24 in FY2025.
Based on SEC 10-K filings.
8.24 in FY2025 with a 5-year CAGR of +40.4%.
Improved from $5.70 to $8.24 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +26.4%
- 5-Year CAGR
- +40.4%
- 10-Year CAGR
- -
Sector benchmark
#56 of 99 in Health CareTop 57% of 99This company $8.24 Sector average $13.99
▼
-41.1% below sector average
Key checks
Key Insights
- Tandem Diabetes Care's gross profit per share has grown for 6 consecutive years.
- In FY2025, gross profit per share increased 10.3% year-over-year.
- Ranks #56 out of 99 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.24 | +10.3% |
| FY2024 | $7.47 | +31.0% |
| FY2023 | $5.70 | +39.6% |
| FY2022 | $4.08 | +31.0% |
| FY2021 | $3.12 | +106.0% |
| FY2020 | $1.51 | +97.4% |
| FY2019 | $0.77 | -67.1% |
| FY2018 | $2.33 | -72.7% |
| FY2017 | $8.55 | +996.0% |
| FY2016 | $0.78 | -30.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026